Established 1963

James T. Christie

Partner
retired
James T. Christie
Contact Info
Tel:
Office Tel:
212.907.0781
Address:
140 Broadway
,
New York, NY 10005

James T. Christie is a Partner in the New York office of Labaton Keller Sucharow LLP.  James focuses on prosecuting complex securities fraud cases on behalf of institutional investors.  He is currently involved in litigating cases against major U.S. and non-U.S. corporations, such as Array, Ericsson, Estee Lauder, Fidelity National Information Services (FIS), iQIYI, Nikola, Novavax, Okta, Opendoor Technologies, and Stone Co.  James also serves as Assistant General Counsel to the Firm and is a Co-Chair of the Firm's Technology Committee.  James is also a member of the Firm’s Executive Committee.

Seen as a rising star insecurities litigation, James has been named a “Next Generation Lawyer” by The Legal 500, a “Rising Star of the Plaintiffs Bar” by The National Law Journal, and has been named to Benchmark Litigation’s “40& Under Hot List.”  He was also recognized by Law360 as a Securities “Rising Star,” noting his leadership in several high-profile matters, and The Best Lawyers in America® listed him as one of the “Best Lawyers in America: Ones to Watch” in the Litigation: Securities category.

James was an integral part of the Firm team that helped recover $192.5 million for investors in a settlement for In re SCANA Corporation Securities Litigation.  James served in a critical role in recovering a $125 million settlement on behalf of investors in Boston Retirement System v. Alexion Pharmaceuticals, Inc. James was a crucial part of a cross-border effort in In re Canntrust Holdings Securities Litigation that was able obtain a landmark CA$129.5million settlement against a Canadian cannabis producer and its executive officers.  James helped lead an effort in fast paced case litigated in the Eastern District of Virginia, In re Jeld-Wen Holding, Inc. Securities Litigation, where the Firm recovered $40 million for injured investors.  In addition, James was a key contributor to the Firm’s efforts in recovering $38 million for investors in a case against a vaccine manufacturer in Sinnathurai v. Novavax, Inc.  James also assisted in recovering $20 million on behalf of investors in a securities class action against LifeLock Inc., where he played a significant role in obtaining a key appellate victory in the Ninth Circuit Court of Appeals reversing the district court’s order dismissing the case with prejudice.  In addition, James assisted in the $14.75 million recovery secured for investors against PTC Therapeutics Inc., a pharmaceutical manufacturer of orphan drugs, in In re PTC Therapeutics, Inc. Securities Litigation.  

James previously served as a Judicial Intern in the U.S. District Court for the Eastern District of New York under the Honorable Sandra J. Feuerstein.

He is an active member of the American Bar Association, the Federal Bar Council, and the Georgia Association of Public Pension Trustees (GAPPT), where he serves on the Rules Committee.

Admissions

2016, New York

U.S. District Court
2016, Southern District of New York
2020, Eastern District of New York
2021, Western District of New York

U.S. Court of Appeals
2017, Second Circuit
2017, Ninth Circuit
2021, Fourth Circuit
2021, Fifth Circuit